Peak Pharmaceuticals, Inc. (OTCMKTS:PKPH – Get Free Report) shares traded down 10.3% during trading on Wednesday . The company traded as low as $3.25 and last traded at $3.50. 850 shares were traded during trading, a decline of 91% from the average session volume of 9,053 shares. The stock had previously closed at $3.90.
Peak Pharmaceuticals Stock Down 10.3 %
The company has a 50-day simple moving average of $4.79 and a two-hundred day simple moving average of $2.62.
Peak Pharmaceuticals Company Profile
Peak Pharmaceuticals, Inc manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ.
See Also
- Five stocks we like better than Peak Pharmaceuticals
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Quantum Computing: The $6.5 Billion Opportunity You Can’t Ignore
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Are Tariffs Threatening Disney’s Comeback Story?
- Upcoming IPO Stock Lockup Period, Explained
- Is Alphabet a Generational Buying Opportunity at These Levels?
Receive News & Ratings for Peak Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Peak Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
